Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
Lassmann
Michael
M
Luster
Markus
M
Hänscheid
Heribert
H
Reiners
Christoph
C
D000328:Adult; D000368:Aged; D001402:B-Lymphocytes / Q000473:pathology / Q000528:radiation effects*; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000528:radiation effects; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000032:analysis / Q000627:therapeutic use*; D008297:Male; D015162:Micronucleus Tests; D008875:Middle Aged; D011832:Radiation Injuries / Q000209:etiology* / Q000235:genetics*; D011874:Radiometry / Q000379:methods; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D013961:Thyroid Gland / Q000473:pathology / Q000528:radiation effects*; D013964:Thyroid Neoplasms / Q000097:blood / Q000473:pathology / Q000532:radiotherapy*
D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals